Actavis Inc (ACT) 188.83 $ACT Facebook, Arris, Grifols

New Post Public Reply Private Reply Replies (0) Message Board

Apr 13, 2014 at 6:12 PM

Actavis Inc (ACT) 188.83 $ACT

Facebook, Arris, Grifols Initiate New Bases
at Investor's Business Daily - Fri Apr 11, 5:35PM CDT
With the stock market in a correction, the investor should emphasize defense. This means keeping cash in the portfolio, cutting losses on any stocks that are falling fast, and taking at least some profits on stocks that trigger key sell signals....

Acura Pharma Ends Agreement with Pfizer - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 4:35PM CDT
Acura Pharmaceuticals entered into a letter agreement with Pfizer in connection with its license agreement for Oxecta.

3 Health Care Stocks Moving The Sector Upward
at The Street - Fri Apr 11, 12:02PM CDT
TheStreet highlights 3 stocks pushing the health care sector higher today.

Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Actavis plc (NYSE: ACT), The Medicines Company (NASDAQ: MDCO), Hospira, Inc. (NYSE: HSP), Horizon Pharma, Inc. (NASDAQ: HZNP), and Galectin Therapeutics Inc. (NASDAQ: GALT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Regulatory Update from Forest Labs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 3:40PM CDT
Forest Labs and partner Almirall announced that the FDA has provided a feedback on their new drug application (NDA) for the fixed dose combination of Tudorza (aclidinium) and formoterol.

Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines
PR Newswire - Thu Apr 10, 11:30AM CDT
On Wednesday, April 09, 2014, the NASDAQ Composite ended at 4,183.90, up 1.72%, the Dow Jones Industrial Average advanced 1.11% to 16,437.18, and the S&P 500 closed at 1,872.18, up 1.09%. The gains were broad based as eight out of 10 sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 673.27, up 2.11%, while the same has declined 2.01% in the last one month. Investor-Edge has initiated coverage on the following equities: Mylan Inc. (NASDAQ: MYL), Actavis PLC (NYSE: ACT), Hospira Inc. (NYSE: HSP) and The Medicines Co. (NASDAQ: MDCO). Free technical research on MYL, ACT, HSP and MDCO can be downloaded upon signing up at:

Stocks Add To Gains; Intuitive Surgical Slumps On Warning
at Investor's Business Daily - Wed Apr 09, 11:04AM CDT
Stocks extended gains Wednesday after Tuesday's lower-volume rally. About two hours into the session, the Nasdaq led the way, up 0.5%. The Dow Jones industrial average and S&P 500 added 0.2% each. NYSE and Nasdaq volume was tracking considerably...

Mallinckrodt plc (MNK) in Focus: Stock Moves 5.3% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Apr 09, 7:37AM CDT
Mallinckrodt plc as the company saw its shares rise more than 5% on the day.

Alexion, Biogen Among Leading Big-Cap Biotechs
at Investor's Business Daily - Wed Apr 09, 7:02AM CDT
Growth stocks are taking a hit now that the market is in a correction. Biotechs saw a recent sell-off over concerns that the sector was overheating, but biotechs and medical stocks are among leading big-cap stocks. IBD's Big Cap Screen of the Day...

Upcoming Results and Conference Call Schedules, New Office Facility, and Stock Price Movements-Analyst Notes on Biogen, Actavis, Bristol-Myers, AbbVie, and Baxter
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Biogen Idec Inc. (NASDAQ: BIIB), Actavis Plc (NYSE: ACT), Bristol-Myers Squibb Co. (NYSE: BMY), AbbVie Inc. (NYSE: ABBV), and Baxter International Inc. (NYSE: BAX). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Pacira and Patheon Collaborate - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 5:10PM CDT
Pacira has signed a strategic co-production partnership deal with Patheon.

Additional Data on Pacira's Exparel - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 08, 4:20PM CDT
Pacira announced additional phase III data on its lead product, Exparel.

Stocks Higher In Late Afternoon; First Solar Jumps
at Investor's Business Daily - Tue Apr 08, 2:02PM CDT
The Nasdaq outperformed in late afternoon trading Tuesday, but gains in the other major indexes were fading. The Nasdaq rose 0.5%, the S&P 500 gained 0.2% and the Dow Jones industrial average slipped 0.1%. NYSE volume was tracking slightly higher...

Stocks Rally, Stall, Turn Mixed; Consol Energy, U.S. Steel Jump
at Investor's Business Daily - Tue Apr 08, 9:29AM CDT
Early gains quickly flickered into a mixed performance Tuesday, with China-based stocks grabbing a large share of early gains. The Nasdaq bobbed to a 0.2% gain. The S&P 500 eased 0.1%. The Dow Jones industrial average dipped 0.2%. Volume was mixed,...

Caesarstone, Other Leaders Show Supporting Action
at Investor's Business Daily - Fri Apr 04, 4:49PM CDT
Even as market volatility increased in recent weeks, some leaders have managed to find support at their 10-week lines or are close to that key moving average. Caesarstone (CSTE) found support at its 10-week moving average two weeks ago. It tested the...

Mylan Rejected In Bid To Acquire Sweden's Meda
at Investor's Business Daily - Fri Apr 04, 11:27AM CDT
Generic-drug giant Mylan (MYL) on Friday lost out in a takeover bid for Swedish counterpart Meda, but its stock was still up more than 4% in midday trading on the stock market. Late Thursday, Britain's Financial Times reported that Mylan and Meda...

Actavis Up Slightly on Silom Acquisition - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 03, 2:56PM CDT
Actavis acquired Thailand-based generic company, Silom Medical Company.

Actavis inaugurates new regional headquarters in Singapore for APACA
M2 - Thu Apr 03, 5:36AM CDT
Pharmaceutical company, Actavis (NYSE:ACT) reported on Wednesday the official opening of its new regional headquarters in Singapore for its Asia Pacific and Africa (APACA) region under its global expansion strategy.

Actavis Launches Asia Pacific Regional Headquarters in Singapore
PR Newswire - Wed Apr 02, 7:00PM CDT
Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced the official opening of its new regional office in Singapore that will serve as the headquarters for the Company's Asia Pacific and Africa (APACA) region.

Four Top World Stocks Offer Follow-On Buy Points
at Investor's Business Daily - Wed Apr 02, 5:11PM CDT
The market's resumed uptrend doesn't come with the clean slate that a sharp correction followed by a follow-through day would offer. A striking eight distribution days levied against the Nasdaq hold out a bright red flag for investors. But the shift...

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

$10,000 Boost Fuels Nichols College's Archaeological Quest

Webster First's Generous Contribution It's not every day you see a credit union digging into history—literally. Webster First Federal Credit Union just dropped ten grand to fuel Nichols College's archaeological adventures. This isn't some trivial check to post on Instagram. No, we're talking about funding some serious ground-penetrating radar (GPR) gadgetry that's set...

Palatin Prepares for FY27 Results Amid Market Curiosity

Mark Your Calendars, Investors! Folks grumble about the mundane task of checking fiscal calendars, but without this intel, where are we? On November 17, 2026, Palatin Technologies (NASDAQ:PTN) is slated to release their Q1 Fiscal Year 2027 operating results bright and early, before most of us have even sipped our coffee. The buzz around these numbers is as electric as any...

Understanding Septic Tank Pumping: Insights & Tips

Why in the world are we discussing septic tanks today? Well, it’s because folks often overlook their importance until they’re knee-deep in unexpected plumbing woes. If you're a homeowner, understanding your septic system's needs is crucial to avoid literal and financial messes down the line. Behind the Scenes of Your Septic System Picture your household water usage....

Anderson University Sees Financial Turnaround Success

Anderson University, against all odds, is shaking up the financial narrative they’ve been stuck in for a while. It’s kind of like finding a $20 bill in an old coat—a nice surprise but it doesn’t happen every day. The university’s recent report on their financial progress is reminding folks that when it comes to fiscal discipline, sometimes you just need fresh...

Dana-Farber Integrates IconPCR for Precise cfDNA Sequencing

Innovating Precision in cfDNA Sequencing One day you're trudging along old paths, and the next, technology throws you a curveball that's too critical to ignore. That's the scene at Dana-Farber Cancer Institute with their latest lab upgrade. They've bent the knee to integrate n6's iconPCR system into their toolkit for liquid biopsy research—a move that's caught my...

Bright Idea: Menu Covers Light Up Dining Spaces

Lighting Up Dinner Conversations You ever sit in a restaurant dim enough to make you question if even the chef can see in that darkness? Enter the MENU AID, a nifty brainchild straight out of Chula Vista, California. This invention brings a bright twist to our dining escapades, literally. Picture a menu cover that lights up like it's got its own little halo, solving the...

Procon Uses Robotics to Revamp Cruise Terminal 5

Building Bigger with Robotics at Port Canaveral Robots on a construction site sounds like sci-fi, right? But it's the reality at Port Canaveral's Cruise Terminal 5, where Procon is rolling out its robotic tech magic. This ain't your everyday wrench-and-spanner job; we're talking remote-controlled bots capturing 360-degree images. “Regular reality capture can help teams...

Etavopivat Aims to Tackle Sickle Cell Crisis Head-On

Diving headfirst into the world of sickle cell disease, Novo Nordisk has just thrown its hat in the ring with etavopivat. Now, anyone who's been following the biotech dance knows this ain't no small feat. This investigational therapy is poised to shake things up, offering a new lifeline for those wrestling with this debilitating condition. And leaping from the Phase 3...

Navigating Roof Damage Insurance Claims: Key Insights

No one wants to deal with roof damage, but knowing the rules of the game is half the battle. The landscape of insurance claims can be tricky—especially when Mother Nature starts playing hard ball. Here, we break down what homeowners need to know to stay one step ahead in these situations. Unpacking Roof Damage Coverage Most homeowners think they've got things covered...

CR&R Workers Join Teamsters, Fight for Fair Conditions

Waste Workers Push Back Against Corporate Pressure The Southern California sun isn't the only thing heating up these days; the waste workers at CR&R Environmental Services have cranked up the heat by voting to join Teamsters Local 396. It's like Groundhog Day in the world of labor rights—same story, different locale, workers banding together for a fair shot. A Stand...